Treatment of urinary tract infection in pregnancy

A CLINICAL STUDY TO EVALUATE THE EFFICACY OF MUTRAVIRAJANEEYA MAHAKASHAYA IN THE MANAGEMENT OF GARBHINI MUTRAKRICCHRA, WITH SPECIAL REFERENCE TO URINARY TRACT INFECTION IN PREGNANCY. - Nil

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/06/112534

Enrollment

Registered

2026-06-11

Start date

Unknown

Completion date

Unknown

Last updated

2026-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: 1- Obstetrics

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Primi Multi Gravida aged between 21 yrs 40 yrs Gestational age 14 weeks 34 weeks Subjects having classical symptoms of Mutrakricchra Sashool Mutrapravrutti, Sadaah Mutrapravrutti, Muhur Muhur Mutrapravrutti Subjects presenting with investigation showing pus cells 5cells HPF in urine

Exclusion criteria

Exclusion criteria: Pre existing chronic renal disorders, Polycystic kidneys, Hydronephrosis, Impaired renal function. Pregnancy induced hypertension. Malignancy of Urinary Tract. Immuno-compromised patients. Gestational Diabetes Mellitus High Risk Pregnancy. Subjects suffering from Sexually Transmitted Disease Allergy to any ingredients of the trial drug

Design outcomes

Primary

Measure	Time frame
No pain and burning and reduced frequency of micturationTimepoint: 21 Days	—

Secondary

Measure	Time frame
Normal urine colour No Pus cells, Albumin, Epithelial Cells, RBC in urineTimepoint: 42 Days	—

Countries

India

Contacts

Public ContactDr Arige Sulochana

DR BRKR Govt Ayurvedic medical college and Hospital Eragadda Hyderabad Telangana

arige.sulochana@gmail.com9347061869

Outcome results